When A Famous Hospital Didn’t Want An Expensive New Drug
by David Kestenbaum
March 28, 2013
extends life for 1.4 months
ZALTRAP®, in combination with 5-fluorouracil, leucovorin, irinotecan-(FOLFIRI), is indicated for patients with metastatic colorectal cancer (mCRC) that is resistant to or has progressed following an oxaliplatin-containing regimen.
In Cancer Care, Cost Matters
By PETER B. BACH, LEONARD B. SALTZ and ROBERT E. WITTES
October 14, 2012